A detailed history of Rock Springs Capital Management LP transactions in Eli Lilly & CO stock. As of the latest transaction made, Rock Springs Capital Management LP holds 142,000 shares of LLY stock, worth $124 Million. This represents 4.28% of its overall portfolio holdings.

Number of Shares
142,000
Previous 121,500 16.87%
Holding current value
$124 Million
Previous $110 Million 14.36%
% of portfolio
4.28%
Previous 3.41%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$772.14 - $960.02 $15.8 Million - $19.7 Million
20,500 Added 16.87%
142,000 $126 Million
Q2 2024

Aug 14, 2024

BUY
$724.87 - $909.04 $13.2 Million - $16.6 Million
18,250 Added 17.68%
121,500 $110 Million
Q1 2024

May 15, 2024

BUY
$592.2 - $792.28 $20 Million - $26.7 Million
33,750 Added 48.56%
103,250 $80.3 Million
Q4 2023

Feb 14, 2024

BUY
$525.19 - $619.13 $36.5 Million - $43 Million
69,500 New
69,500 $40.5 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $827B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Rock Springs Capital Management LP Portfolio

Follow Rock Springs Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rock Springs Capital Management LP with notifications on news.